On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.
May 28th 2024
After initiating treatment with ixekizumab, tender and swollen joint counts, pain, fatigue, and body surface area affected by psoriasis were significantly improved.
10 Worst Things Physicians Say to Patients
June 14th 2016Whether delivered intentionally or not, some physician comments are unhelpful at best and low-blows at worst. Saying certain things to patients can actually increase your risk of having a malpractice suit filed against you, making it especially important for you to always be mindful when speaking with patients.
Tips for Talking to a Dying Patient
May 11th 2016When a patient is dying, it can be difficult to know what to say to them. Here are a few tips and approaches that I have gathered from experts that I hope will help you get through those hard conversations while continuing to provide the best possible care to your patient.
Balancing Treatment and Disease Burden of Arthritis in Young Patients
Researchers explored how people aged 16 to 25 years old with inflammatory arthritis evaluate the risks and benefits of treatment. They especially wanted to focus on the patients’ assessments of biologic therapies.
Timely Use of Tumor Necrosis Factor Inhibitors Effectively Manages Psoriatic Arthritis
A new analysis of treatment costs and trial outcomes concludes that immediate use of tumor necrosis factor inhibitors (TNFis) is a cost-effective strategy for managing psoriatic arthritis patients with both skin and joint involvement but not for managing those patients with joint disease alone.
Joint Pain and Synovitis Linked to Increased Psoriatic Arthritis Risk in Patients with Psoriasis
A new trial of magnetic resonance imaging finds that analyzing scans for subclinical signs of inflammatory joint disease can help predict which psoriasis patients will go on to develop psoriatic arthritis.
Etanercept Safe and Effective for Juvenile Psoriatic Arthritis
A 96-week-long trial of etanercept (Enbrel) indicates durable therapeutic benefits and no serious adverse events in pediatric patients with psoriatic arthritis and other types of juvenile idiopathic arthritis.
5 Factors that Predict Medication Nonadherence in Patients Taking Biologics for Rheumatic Disease
Analysis of questionnaire data has identified 5 factors that help predict which patients with chronic inflammatory rheumatic diseases such as psoriatic arthritis will abandon biologic treatment.
Presidential Candidates on Health Care Issues: Bernie Sanders
Part of an ongoing series that takes a high-level look at the positions of the leading nominees for President when it comes to political issues potentially impacting physicians, this installment focuses on Bernie Sanders.